SG
Sudipta Ghosh
About Sudipta Ghosh
Data last updated:
Sudipta Ghosh is a Whole-Time Director at Revenza Pharmaceuticals Private Limited (since 2016) and Individual Subscriber at Nephro Immune Dialysis Medicine Private Limited (since 2026). The companies operate in Pharma. The largest current company by reported revenue is Revenza Pharmaceuticals Private Limited at ₹3.85 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Revenza Pharmaceuticals Private Limited U24100WB2016PTC209990 | Whole-Time Director | 26 Feb 2016 | 2016 | ₹3.85 Cr (FY 2024) | Active |
| Nephro Immune Dialysis Medicine Private Limited U46497WB2026PTC289320 | Individual Subscriber | 20 Aug 2026 | 2026 | Active |
Board colleagues of Sudipta Ghosh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhijit Majumdar | 07372738 | Revenza Pharmaceuticals Private Limited , Nephro Immune Dialysis Medicine Private Limited | Whole-Time Director |
| Arindam Chakraborty | 07372752 | Revenza Pharmaceuticals Private Limited | Whole-Time Director |
| Sunil Samaddar | 07372876 | Revenza Pharmaceuticals Private Limited | Whole-Time Director |
| Aditi Chatterjee | 11871406 | Nephro Immune Dialysis Medicine Private Limited | Director |
| Atanu Pal | Nephro Immune Dialysis Medicine Private Limited | Individual Subscriber | |
| Krishna Deo Thakur | 10884905 | Nephro Immune Dialysis Medicine Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sudipta Ghosh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sudipta Ghosh
Sudipta Ghosh currently holds 2 directorships: Revenza Pharmaceuticals Private Limited (Whole-Time Director, since 26 Feb 2016, revenue ₹3.85 Cr (FY 2024)); Nephro Immune Dialysis Medicine Private Limited (Individual Subscriber, since 20 Aug 2026).
Sudipta Ghosh was first appointed on 26 Feb 2016 as Whole-Time Director at Revenza Pharmaceuticals Private Limited. The most recent appointment on record is 20 Aug 2026 at Nephro Immune Dialysis Medicine Private Limited.
The current boards of Sudipta Ghosh's companies include Abhijit Majumdar (Revenza Pharmaceuticals Private Limited), Arindam Chakraborty (Revenza Pharmaceuticals Private Limited), Sunil Samaddar (Revenza Pharmaceuticals Private Limited), Aditi Chatterjee (Nephro Immune Dialysis Medicine Private Limited), Atanu Pal (Nephro Immune Dialysis Medicine Private Limited), Krishna Deo Thakur (Nephro Immune Dialysis Medicine Private Limited).